See Remarks of Bridgebio Pharma, Inc. (NASDAQ:BBIO), Turtle Cameron, sells 4,258 shares worth $200,137
According to Bridgebio Pharma, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 25 09:54 PM, company See Remarks, Turtle Cameron disclosed selling 4,258 shares at a cost of $47.00. At the time of this transaction (Nov 24), this trade was worth $200,137 in total. As of Nov 24, Turtle Cameron now owns 12,568 shares in total worth about $609,170.96.
For the last few recent trades made by Bridgebio Pharma, Inc. (NASDAQ:BBIO) See Remarks, Turtle Cameron, we have the following information:
- SEC Form 4 filing: Nov 25: Sold 742 shares at the rate of $47.23 per share. Total worth of this trade was $35,044. Total number of shares owned as of Nov 25 were 12,568
- SEC Form 4 filing: Nov 05: Sold 2,500 shares at the rate of $42.05 per share. Total worth of this trade was $105,125. Total number of shares owned as of Nov 05 were 12,568
- SEC Form 4 filing: Sep 30: Sold 14,500 shares at the rate of $37.69 per share. Total worth of this trade was $546,458. Total number of shares owned as of Sep 30 were 12,568
Posted by
George Daniels
on Thursday November 26 2020, 3:22 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
